Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Angiotensin type 2 receptor activation limits kidney injury during the early phase and induces Treg cells during the late phase of renal ischemia

American Journal of Physiology-Renal Physiology(2021)10.1152/ajprenal.00507.2020Source: DataRank Database

Angiotensin type 2 receptor activation limits kidney injury during the early phase and induces Treg cells during the late phase of renal ischemia is a research paper published in American Journal of Physiology-Renal Physiology (2021). On theSindex it has a DataRank of 0. It has been cited 24 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access24 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.39)OA: greenTopics (39)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Sanket Patel ORCID,Tahir Hussain ORCID,Riyasat Ali ORCID

Live enrichment

PubMed:33719572 PMC:PMC8424555 OpenAlex:https://openalex.org/W3137436996

HHS | National Institutes of Health

Grant: R01DK117495

HHS | National Institutes of Health

Grant: R01DK61578

NIDDK NIH HHS

Grant: R01 DK061578

FWCI

1.39

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

2024

2025

2026

green

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8424555

publisherhttps://journals.physiology.org/doi/pdf/10.1152/ajprenal.00507.2020

journalhttps://doi.org/10.1152/ajprenal.00507.2020

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33719572

Fields of Study

Complement system in diseasesRenin-Angiotensin System StudiesAcute Kidney Injury Research

MeSH Terms

AnimalsAnti-Inflammatory AgentsChemotaxis, LeukocyteDisease Models, AnimalKidneyPhenotypeSulfonamidesThiophenesTime FactorsSignal TransductionReperfusion InjuryCytokinesRats, Sprague-DawleyReceptor, Angiotensin, Type 2T-Lymphocytes, RegulatoryRatsAcute Kidney Injury

Keywords

KidneyIschemiaImmune systemAgonistAngiotensin IIFOXP3MedicineAcute kidney injuryRenal ischemiaReceptorRenin–angiotensin systemEndocrinologyImmunologyInternal medicineReperfusion injuryIschemia-reperfusion injuryInterleukin-10Angiotensin Ii Type 2 ReceptorC21

Sustainable Development Goals

SDG 0: Good health and well-being

Angiotensin type 2 receptor activation limits kidney injury during the early phase and induces Treg cells during the late phase of renal ischemia

FAIR Checklist

Authors (3)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)